$2.81
0.07[2.55%]
At close: Apr 26
$2.81
0[0.00%]
After Hours: 7:58PM EDT
T2 Biosystems: Insider buying and selling updated today.
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
---|---|---|---|---|---|---|---|---|---|---|
Sep 29, 2023 | CR Group LPCRG Partners III LPCRG Partners III Parallel Fund A LPCRG Partners III Cayman Unlev AIV I LPCRG Partners III Cayman Lev AIV I LP | 10% OWNER | -13.130147M | $0.17 | -$2.27M | SELL | -100.00% | 0 | Sep 27 - Sep 28 | View |
Sep 28, 2023 | CR Group LPCRG Partners III LPCRG Partners III Parallel Fund A LPCRG Partners III Cayman Unlev AIV I LPCRG Partners III Cayman Lev AIV I LP | 10% OWNER | -5.39292M | $0.20 | -$1.08M | SELL | -60.24% | 3.559165M | Sep 26 | View |
Sep 27, 2023 | CR Group LPCRG Partners III LPCRG Partners III Parallel Fund A LPCRG Partners III Cayman Unlev AIV I LPCRG Partners III Cayman Lev AIV I LP | 10% OWNER | -250K | $0.25 | -$62.50K | SELL | -4.74% | 5.021014M | Sep 25 | View |
Sep 26, 2023 | CR Group LPCRG Partners III LPCRG Partners III Parallel Fund A LPCRG Partners III Cayman Unlev AIV I LPCRG Partners III Cayman Lev AIV I LP | 10% OWNER | -5.079344M | $0.26 | -$1.31M | SELL | -49.95% | 5.088781M | Sep 22 | View |
Sep 25, 2023 | CR Group LPCRG Partners III LPCRG Partners III Parallel Fund A LPCRG Partners III Cayman Unlev AIV I LPCRG Partners III Cayman Lev AIV I LP | 10% OWNER | -6.338211M | $0.30 | -$1.90M | SELL | -49.50% | 6.465629M | Sep 21 | View |
Sep 22, 2023 | CR Group LPCRG Partners III LPCRG Partners III Parallel Fund A LPCRG Partners III Cayman Unlev AIV I LPCRG Partners III Cayman Lev AIV I LP | 10% OWNER | -7.75371M | $0.31 | -$2.41M | SELL | -48.65% | 8.183716M | Sep 20 | View |
Sep 21, 2023 | CR Group LPCRG Partners III LPCRG Partners III Parallel Fund A LPCRG Partners III Cayman Unlev AIV I LPCRG Partners III Cayman Lev AIV I LP | 10% OWNER | -10.401466M | $0.37 | -$3.81M | SELL | -50.28% | 10.2855M | Sep 19 | View |
Apr 06, 2023 | Terrence Michael Gibbs | GENERAL COUNSEL | -239 | $0.48 | -$114.96 | SELL | -3.49% | 6.612K | Mar 28 | View |
Mar 09, 2023 | Brett Giffin | CHIEF COMMERCIAL OFFICER | 796 | $0.65 | -$349.05 | SELL-OPTIONS | 1768.89% | 841 | Feb 20 - Feb 22 | View |
Mar 09, 2023 | John Sprague Attorney-in-fact | CHIEF FINANCIAL OFFICER | 4.221K | $0.62 | -$1.68K | SELL-OPTIONS | 138.53% | 7.268K | Feb 20 - Feb 28 | View |
Mar 09, 2023 | Terrence Michael Gibbs | GENERAL COUNSEL | 3.184K | $0.62 | -$2.33K | SELL-OPTIONS | 95.53% | 6.517K | Feb 20 - Feb 28 | View |
Mar 09, 2023 | John Sperzel III | CHAIRMAN AND CEO | 12.894K | $0.63 | -$6.18K | SELL-OPTIONS | 290.73% | 17.329K | Feb 20 - Feb 28 | View |
Nov 22, 2022 | Brett Giffin | CHIEF COMMERCIAL OFFICER | 2.041K | $1.79 | -$2.32K | SELL-OPTIONS | 962.74% | 2.253K | Nov 08 - Nov 10 | View |
Apr 11, 2022 | John Sperzel III | CHAIRMAN, CEO, AND PRESIDENT | 30K | $0.50 | $15.00K | BUY | 15.64% | 221.773K | Apr 07 | View |
Apr 11, 2022 | Alec Barclay | CHIEF OPERATIONS OFFICER | 12.95188K | $0.50 | $6.48K | BUY | 7.66% | 181.94488K | Apr 08 | View |
Apr 11, 2022 | Terrence Michael Gibbs | GENERAL COUNSEL | 10K | $0.49 | $4.90K | BUY | 6.38% | 166.651K | Apr 07 | View |
Apr 11, 2022 | John Sprague | CHIEF FINANCIAL OFFICER | 10K | $0.48 | $4.77K | BUY | 7.02% | 152.35K | Apr 08 | View |
Apr 11, 2022 | Brett Giffin | CHIEF COMMERCIAL OFFICER | 10.6K | $0.49 | $5.18K | BUY | ∞ | 10.6K | Apr 08 | View |
Jan 10, 2022 | Aparna Ahuja | CHIEF MEDICAL OFFICER | -61.988K | $0.48 | -$29.75K | SELL | -36.55% | 107.611K | Jan 06 | View |
Browse insider trades on all stocks.